Src family kinase activation in glycosphingolipid-rich membrane domains of endothelial cells treated with oxidised low density lipoprotein.
Extraction of ECV304 endothelial cells in 1% Triton X-100 at 4 degrees C resulted in a detergent-insoluble pellet that contained 90% of the caveolin, 78% of the src family kinases and 99% of the annexin II. When detergent-treated cells were loaded beneath a 10-30% sucrose gradient the caveolin and a large proportion of the cellular cholesterol floated at a density of 1.09 g/cm3, characteristic of caveolae and glycosphingolipid-rich membranes. With extended centrifugation the src family kinases, which were initially associated with this floating material, sedimented to the bottom of the gradient. Annexin II remained on the bottom of the gradient under both centrifugation conditions. After 24-h incubation with oxidised low density lipoprotein (oxLDL) about 7.5% of the total sterol in the cells was replaced by 7-ketocholesterol, the major oxysterol found in oxLDL. The majority of this 7-ketocholesterol was found in the light membrane fraction on sucrose gradients. Under these conditions src kinase activity more than doubled in the Triton-resistant fraction, without changes in the concentration of src kinase protein. Introducing oxysterols directly into the medium bathing ECV304 cells for 1 h also modulated the activity of src family kinases in the detergent-resistant membranes. An elevation in activity was observed for 7-ketocholesterol while 7alpha-hydroxycholesterol, 7alpha-hydroxycholesterol and cholesterol epoxide all produced decreases in the background level of src kinase activity. We conclude that 7-ketocholesterol and possibly other components of oxLDL can equilibrate into glycosphingolipid-rich membranes and increase the activity of src kinases, possibly by interaction with caveolin.
Myers
S J
SJ
The Heart Research Institute, NSW, Sydney, Australia.
Stanley
K K
KK
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D051242:Caveolin 1; D022461:Caveolins; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D004789:Enzyme Activation; D006028:Glycosphingolipids / Q000378:metabolism*; D006801:Humans; D007653:Ketocholesterols / Q000032:analysis; D008077:Lipoproteins, LDL / Q000378:metabolism* / Q000494:pharmacology; D008565:Membrane Proteins / Q000378:metabolism* / Q000648:ultrastructure; D051379:Mice; D015388:Organelles / Q000378:metabolism; D011505:Protein-Tyrosine Kinases / Q000032:analysis / Q000378:metabolism*; D012680:Sensitivity and Specificity; D019061:src-Family Kinases / Q000378:metabolism*
D015415:Biomarkers; C495540:CAV1 protein, human; C495541:Cav1 protein, mouse; D051242:Caveolin 1; D022461:Caveolins; D006028:Glycosphingolipids; D007653:Ketocholesterols; D008077:Lipoproteins, LDL; D008565:Membrane Proteins; D011505:Protein-Tyrosine Kinases; D019061:src-Family Kinases; C003001:7-ketocholesterol